Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of GSK HPV-16/18 AS04 vaccine 2-dose schedule in 4–6-year-old girls
2011-005604-15Phase 3
- Sponsor
- GSK
- Start
- Oct 2015
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine in Cervical Cancer (CC), sponsored by GSK.
02
Drugs
Human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2011-005604-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005604-15.